Leading Financial Service Provider in India | Canara Bank Securities Ltd

Vanta Bioscience Ltd.

Jun 05 BSE 22.02 ( -1.15 -4.96%)

Volume750

Prev. Close
23.17

Open Price
22.02

Today's Low / High

22.02 22.02

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

14.71 31.33

Vanta Bioscience Ltd.is not traded in NSE

Market Cap. ( ₹ in Cr. )	15.66	P/BV	0.81	Book Value ( ₹ )	27.06
52 Week High/Low ( ₹ )	31/15	FV/ML	10/750	P/E(X)	144.87
Book Closure		EPS ( ₹ )	0.15	Div Yield (%)	0.00

(₹ in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	71.12	63.12	63.12	63.12	63.12

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	7.11	6.31	6.31	6.31	6.31
Total Share Capital	7.11	6.31	6.31	6.31	6.31

Reserves and Surplus	14.06	4.11	8.89	11.20	17.70
Total Reserves and Surplus	14.06	4.11	8.89	11.20	17.70
Total Shareholders Funds	21.18	10.42	15.20	17.51	24.01
Minority Interest	0.00	-6.64	-2.23	1.41	5.34

NON-CURRENT LIABILITIES
Long Term Borrowings	31.21	54.13	48.80	47.07	37.00
Deferred Tax Liabilities [Net]	0.65	1.41	0.75	0.97	0.78
Other Long Term Liabilities	1.25	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	33.11	55.53	49.55	48.03	37.78

CURRENT LIABILITIES
Short Term Borrowings	6.87	15.96	12.15	10.09	7.87
Trade Payables	1.61	4.94	5.57	4.22	2.46
Other Current Liabilities	3.34	5.66	5.16	3.43	3.91
Short Term Provisions	0.00	0.00	0.00	0.00	0.04
Total Current Liabilities	11.82	26.56	22.88	17.75	14.28

Total Capital And Liabilities	66.10	85.88	85.40	84.71	81.40

ASSETS
NON-CURRENT ASSETS
Tangible Assets	9.68	23.96	28.41	33.23	14.54
Intangible Assets	38.40	31.54	25.75	24.00	21.59
Capital Work-In-Progress	0.00	0.00	0.00	0.00	22.78
Intangible Assets Under Development	0.00	13.47	12.53	10.60	5.69
Fixed Assets	48.08	68.97	66.69	67.83	64.59
Non-Current Investments	3.00	0.00	0.00	0.00	0.00
Long Term Loans And Advances	0.88	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.01	1.56	1.55	1.64	2.32
Total Non-Current Assets	51.97	70.52	68.24	69.47	66.91


CURRENT ASSETS
Inventories	7.53	6.51	7.52	7.16	7.24
Trade Receivables	2.56	2.50	3.14	1.96	1.13
Cash And Cash Equivalents	0.14	0.22	0.16	0.10	0.22
Short Term Loans And Advances	3.38	5.63	5.77	5.38	5.18
OtherCurrentAssets	0.53	0.50	0.56	0.65	0.72
Total Current Assets	14.13	15.36	17.16	15.24	14.50

Total Assets	66.10	85.88	85.40	84.71	81.40

Particulars	Mar 26
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR
FaceValue	10.00
No. of Equity Shares (in Lacs)	71.12

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	7.11
Total Share Capital	7.11
Reserves and Surplus	14.06
Total Reserves and Surplus	14.06
Total Shareholders Funds	21.18
Minority Interest	0.00
NON-CURRENT LIABILITIES
Long Term Borrowings	31.21
Deferred Tax Liabilities [Net]	0.65
Other Long Term Liabilities	1.25
Total Non-Current Liabilities	33.11
CURRENT LIABILITIES
Short Term Borrowings	6.87
Trade Payables	1.61
Other Current Liabilities	3.34
Short Term Provisions	0.00
Total Current Liabilities	11.82
Total Capital And Liabilities	66.10
ASSETS
NON-CURRENT ASSETS
Tangible Assets	9.68
Intangible Assets	38.40
Capital Work-In-Progress	0.00
Intangible Assets Under Development	0.00
Fixed Assets	48.08
Non-Current Investments	3.00
Long Term Loans And Advances	0.88
Other Non-Current Assets	0.01
Total Non-Current Assets	51.97
CURRENT ASSETS
Inventories	7.53
Trade Receivables	2.56
Cash And Cash Equivalents	0.14
Short Term Loans And Advances	3.38
OtherCurrentAssets	0.53
Total Current Assets	14.13
Total Assets	66.10

Markets

Balance Sheet

BALANCE SHEET

Vanta Bioscience Ltd.